Recent Finacing
Recent Raise
Pherecydes Pharma develops precision bacteriophage therapeutics for antibiotic‑resistant infections, runs clinical trials and compassionate use, and operates GMP phage production and R&D for S. aureus, E. coli, P. aeruginosa.
